WILMINGTON, DEL. (CN) - King Pharmaceutical sued Alpharma in Chancery Court to try to force it to accept King's buyout offer of $33 a share, a 45% premium over Alpharma's pre-offer stock price, or a second offer of $37 a share. King says Alpharma rushed through "poison pill" shareholder provisions to fight the buyout, and that it hurt its shareholders in doing so.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026